Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 21, 2021

SELL
$2.63 - $3.67 $33,177 - $46,297
-12,615 Closed
0 $0
Q1 2021

Apr 05, 2021

BUY
$2.82 - $5.6 $3,919 - $7,783
1,390 Added 12.38%
12,615 $45,000
Q4 2020

Jan 20, 2021

BUY
$2.09 - $3.09 $8,744 - $12,928
4,184 Added 59.42%
11,225 $28,000
Q3 2020

Oct 19, 2020

BUY
$2.39 - $3.43 $16,827 - $24,150
7,041 New
7,041 $18,000
Q4 2018

Feb 13, 2019

SELL
$1.61 - $3.62 $17,771 - $39,957
-11,038 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$2.26 - $3.27 $24,945 - $36,094
11,038 New
11,038 $35,000
Q1 2018

May 14, 2018

SELL
$3.46 - $5.14 $10,293 - $15,291
-2,975 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$4.0 - $6.54 $11,900 - $19,456
2,975
2,975 $12,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $443M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.